The global ertapenem injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Ertapenem injection is prescribed primarily to treat high-risk and serious bacterial infections including urinary tract, skin, diabetic, foot, gynaecological, pelvic, and abdominal infection. It is also used after surgery to prevent infections. The ertapenem injection market is witnessing significant growth during the forecast period, due to the increasing prevalence of infection across the globe. According to the Centres for Disease Control and Prevention 2019, around 2.8 million populations get affected by bacterial infection and 35,000 deaths every year are caused by antibiotic-resistant bacteria and fungi in the US.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-ertapenem-injection/92768/
Additionally, the rising need and demand for minimally invasive surgeries globally is another factor which is expected to bolster the growth of the ertapenem injection market. as this injection is also prescribed after several surgeries to prevent infections. According to the article by the US National Library of Medicine in December 2021, an estimation of 13,108,567 surgical procedures was identified from January 1, 2019, to January 30, 2021, in the US.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– Merck & Co., Inc., Endo International plc, Aurobindo Pharma, and ACS Dobfar S.p.A. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Ertapenem Injection Market Report by Segment
By Type
- INVANZ
- Generic Version
By Indication
- Children
- Adults
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on omrindustryjournal Market Post.
omrindustryjournal Market Post is not responsible for any content included in this release.
